The Deutsche Apotheker- und Ärztebank (apoBank) and AXA Germany are combining their sales activities. The merger of the mobile sales agencies Deutsche Ärzte Finanz (DÄF) and apoFinanz will create the largest financial sales organisation for academic healthcare professions in Germany.
As part of the transaction, apoFinanz, in which apoBank and Deutsche Ärzteversicherung (DÄV) as part of the AXA Group currently hold a 50% stake each, will be merged into DÄF. apoBank will then increase its stake in DÄF to 49%, with the remaining 51% held by AXA Germany. The transaction is expected to be closed in August 2025.
Hengeler Mueller advised AXA Germany comprehensively on the transaction.
Team AXA Germany
Legal: Matthias Friedrich (Head of Corporate, Supervisory Law & Contract), Stefanie Bischof-Hennecke
Tax: Christoph Rummel (Head of Tax), Lydia Doppelfeld, Bastian Faustmann
Hengeler Mueller team for AXA Germany
Corporate/M&A: Carl-Philipp Eberlein (partner, lead), Marc Zuber (counsel, both Düsseldorf),
Antitrust: Markus Röhrig (partner), Christoph M. Sielmann (senior associate, both Brussels),
Tax: Markus Ernst (partner, Munich), Sebastian Heinrichs (counsel, Frankfurt).